Search Within

Kenneth Ho-Ming Yu

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (20)
  2. Meeting Abstract (15)
Groups
  1. Center for Pancreatic Cancer Research (35)
  2. Department of Medicine (35)
  3. Gastrointestinal Oncology Service (35)
  4. Sloan Kettering Institute Postdocs (35)
  5. Solid Tumor Oncology Division (35)
  6. GSK Faculty (29)

More Groups

People
  1. Eileen O'Reilly (26)
  2. Anna Varghese (15)
  3. Christine Iacobuzio-Donahue (15)
  4. Marinela Capanu (12)
  5. Wungki Park (12)
  6. David Kelsen (11)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2022 (4)
  4. 2021 (6)
  5. 2020 (5)
  6. 2019 (3)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Clinical Cancer Research (3)
  3. Journal of Nuclear Medicine (3)
  4. Cancer Research (2)
  5. Cancers (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (6)
  3. Society of Nuclear Medicine (3)
  4. MDPI (2)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Lynch syndrome and somatic mismatch repair variants in pancreas cancer
    Journal Article

    O'Connor, C. A.; Harrold, E.; Lin, D.; Walch, H.; Gazzo, A.; Ranganathan, M.; Kane, S.; Keane, F.; Schoenfeld, J.; Moss, D.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Somatic mismatch repair deficiency in pancreas cancer (PC): Immune checkpoint blockade (ICB) outcomes and exploratory genomic analyses
    Meeting Abstract

    O'Connor, C. A.; Harrold, E.; Lin, Y. T.; Walch, H. S.; Gazzo, A.; Kane, S. R.; Keane, F.; Schoenfeld, J. D.; Moss, D.; Suehnholz, S. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Methylation analyses reveal promoter hypermethylation as a rare cause of “second hit” in germline BRCA1-associated pancreatic ductal adenocarcinoma
    Journal Article

    Zheng-Lin, B.; Rainone, M.; Varghese, A. M.; Yu, K. H.; Park, W.; Berger, M.; Mehine, M.; Chou, J.; Capanu, M.; Mandelker, D.; more...
    Molecular Diagnosis and Therapy (2022)

    Fulltext@MSK | Save
  • Clinico-genomic characterization of ATM and HRD in pancreas cancer: Application for practice
    Journal Article

    Park, W.; O'Connor, C. A.; Bandlamudi, C.; Forman, D.; Chou, J. F.; Umeda, S.; Reyngold, M.; Varghese, A. M.; Keane, F.; Balogun, F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Concurrent germline BRCA1/2 and mismatch repair mutations in young-onset pancreatic and colorectal cancer: The importance of comprehensive germline and somatic characterization to inform therapeutic options
    Journal Article

    Ozer, M.; Ranganathan, M.; Lecomte, N.; Schvartzman, J. M.; Walch, H. S.; Chatila, W. K.; Hong, J.; Carlo, M. I.; Walsh, M. F.; Sheehan, M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma
    Journal Article

    McIntyre, C. A.; Cohen, N. A.; Goldman, D. A.; Gonen, M.; Sadot, E.; O'Reilly, E. M.; Varghese, A. M.; Yu, K. H.; Balachandran, V. P.; Soares, K. C.; more...
    Journal of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Local control and survival after induction chemotherapy and ablative radiation versus resection for pancreatic ductal adenocarcinoma with vascular involvement
    Journal Article

    Jolissaint, J. S.; Reyngold, M.; Bassmann, J.; Seier, K. P.; Gönen, M.; Varghese, A. M.; Yu, K. H.; Park, W.; O'Reilly, E. M.; Balachandran, V. P.; more...
    Annals of Surgery (2021)

    Fulltext@MSK | Save